Real-World Continuous EEG Utilization and Outcomes in Hospitalized Patients With Acute Cerebrovascular Diseases
- PMID: 37938032
- PMCID: PMC11058112
- DOI: 10.1097/WNP.0000000000001043
Real-World Continuous EEG Utilization and Outcomes in Hospitalized Patients With Acute Cerebrovascular Diseases
Abstract
Purpose: Continuous electroencephalography (cEEG) is recommended for hospitalized patients with cerebrovascular diseases and suspected seizures or unexplained neurologic decline. We sought to (1) identify areas of practice variation in cEEG utilization, (2) determine predictors of cEEG utilization, (3) evaluate whether cEEG utilization is associated with outcomes in patients with cerebrovascular diseases.
Methods: This cohort study of the Premier Healthcare Database (2014-2020), included hospitalized patients age > 18 years with cerebrovascular diseases (identified by ICD codes). Continuous electroencephalography was identified by International Classification of Diseases (ICD)/Current Procedural Terminology (CPT) codes. Multivariable lasso logistic regression was used to identify predictors of cEEG utilization and in-hospital mortality. Propensity score-matched analysis was performed to determine the relation between cEEG use and mortality.
Results: 1,179,471 admissions were included; 16,777 (1.4%) underwent cEEG. Total number of cEEGs increased by 364% over 5 years (average 32%/year). On multivariable analysis, top five predictors of cEEG use included seizure diagnosis, hospitals with >500 beds, regions Northeast and South, and anesthetic use. Top predictors of mortality included use of mechanical ventilation, vasopressors, anesthetics, antiseizure medications, and age. Propensity analysis showed that cEEG was associated with lower in-hospital mortality (Average Treatment Effect -0.015 [95% confidence interval -0.028 to -0.003], Odds ratio 0.746 [95% confidence interval, 0.618-0.900]).
Conclusions: There has been a national increase in cEEG utilization for hospitalized patients with cerebrovascular diseases, with practice variation. cEEG utilization was associated with lower in-hospital mortality. Larger comparative studies of cEEG-guided treatments are indicated to inform best practices, guide policy changes for increased access, and create guidelines on triaging and transferring patients to centers with cEEG capability.
Copyright © 2023 by the American Clinical Neurophysiology Society.
Conflict of interest statement
Potential conflicts of interest
Dr. Amerineni is a data scientist for CertainTeed unrelated to this work. Dr. Zafar is a clinical neurophysiologist for Corticare, unrelated to this work.
Dr. Westover is cofounder of Beacon Biosignals unrelated to this work.
References
-
- Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37(6):2051–2056. - PubMed
-
- Kurtz P, Gaspard N, Wahl AS, et al. Continuous electroencephalography in a surgical intensive care unit. Intensive Care Med. 2014;40(2):228–234. - PubMed
-
- Rodriguez Ruiz A, Vlachy J, Lee JW, et al. Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients. JAMA Neurol. 2017;74(2):181–188. - PubMed
-
- Zafar SF, Subramaniam T, Osman G, Herlopian A, Struck AF. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav. - PubMed
MeSH terms
Grants and funding
- R01 NS102190/NS/NINDS NIH HHS/United States
- R01 HL141505/HL/NHLBI NIH HHS/United States
- RF1 AG064312/AG/NIA NIH HHS/United States
- R01 HD097778/HD/NICHD NIH HHS/United States
- R01 AG062282/AG/NIA NIH HHS/United States
- R01 NS102574/NS/NINDS NIH HHS/United States
- K08 AG055670/AG/NIA NIH HHS/United States
- P01 AG032952/AG/NIA NIH HHS/United States
- K23 NS114201/NS/NINDS NIH HHS/United States
- R01 NS107291/NS/NINDS NIH HHS/United States
- U01 FD007213/FD/FDA HHS/United States
- K08 AG053380/AG/NIA NIH HHS/United States
- K23NS114201/GF/NIH HHS/United States
LinkOut - more resources
Full Text Sources